William M. Hurni

1.5k total citations
25 papers, 804 citations indexed

About

William M. Hurni is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, William M. Hurni has authored 25 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Molecular Biology and 9 papers in Hepatology. Recurrent topics in William M. Hurni's work include Hepatitis B Virus Studies (8 papers), Hepatitis Viruses Studies and Epidemiology (7 papers) and Hepatitis C virus research (6 papers). William M. Hurni is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Hepatitis Viruses Studies and Epidemiology (7 papers) and Hepatitis C virus research (6 papers). William M. Hurni collaborates with scholars based in United States, France and Germany. William M. Hurni's co-authors include David R. Nalin, Joseph G. Joyce, Leora Brown, William J. Miller, Xiaoping Liang, Barbara J. Kuter, Paul M. Keller, Loren D. Schultz, Renee Danzeisen and Michael J. Bogusky and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemistry.

In The Last Decade

William M. Hurni

23 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William M. Hurni United States 13 392 238 219 212 189 25 804
Mary Clare Walker United States 11 229 0.6× 367 1.5× 646 2.9× 257 1.2× 80 0.4× 25 911
Santiago Dueñas‐Carrera Cuba 17 380 1.0× 78 0.3× 75 0.3× 164 0.8× 439 2.3× 46 655
Julie A. Waterbury United States 6 134 0.3× 194 0.8× 604 2.8× 226 1.1× 69 0.4× 6 767
Elissa Malkin United States 17 433 1.1× 364 1.5× 95 0.4× 207 1.0× 55 0.3× 21 1.6k
Li‐Hua Ping United States 8 208 0.5× 238 1.0× 532 2.4× 326 1.5× 167 0.9× 16 910
Kathie Grovit‐Ferbas United States 14 306 0.8× 549 2.3× 894 4.1× 228 1.1× 75 0.4× 15 1.2k
James A. Bradac United States 15 231 0.6× 218 0.9× 529 2.4× 161 0.8× 34 0.2× 22 733
E K Cobb United States 13 441 1.1× 397 1.7× 805 3.7× 262 1.2× 24 0.1× 13 1.1k
Marintha Heil United States 14 269 0.7× 241 1.0× 651 3.0× 140 0.7× 85 0.4× 21 939
M J McElrath United States 12 375 1.0× 381 1.6× 528 2.4× 132 0.6× 36 0.2× 13 960

Countries citing papers authored by William M. Hurni

Since Specialization
Citations

This map shows the geographic impact of William M. Hurni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William M. Hurni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William M. Hurni more than expected).

Fields of papers citing papers by William M. Hurni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William M. Hurni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William M. Hurni. The network helps show where William M. Hurni may publish in the future.

Co-authorship network of co-authors of William M. Hurni

This figure shows the co-authorship network connecting the top 25 collaborators of William M. Hurni. A scholar is included among the top collaborators of William M. Hurni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William M. Hurni. William M. Hurni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGaughey, Georgia B., Gaetano Barbato, Elisabetta Bianchi, et al.. (2004). Progress Towards the Development of a HIV-1 gp41-Directed Vaccine. Current HIV Research. 2(2). 193–204. 42 indexed citations
2.
Joyce, Joseph G., William M. Hurni, Michael J. Bogusky, et al.. (2002). Enhancement of α-Helicity in the HIV-1 Inhibitory Peptide DP178 Leads to an Increased Affinity for Human Monoclonal Antibody 2F5 but Does Not Elicit Neutralizing Responses in Vitro. Journal of Biological Chemistry. 277(48). 45811–45820. 96 indexed citations
3.
Cook, James C., Joseph G. Joyce, Hugh A. George, et al.. (1999). Purification of Virus-like Particles of Recombinant Human Papillomavirus Type 11 Major Capsid Protein L1 from Saccharomyces cerevisiae. Protein Expression and Purification. 17(3). 477–484. 90 indexed citations
4.
Lowe, Robert S., Darron R. Brown, Janine T. Bryan, et al.. (1997). Human Papillomavirus Type 11 (HPV‐11) Neutralizing Antibodies in the Serum and Genital Mucosal Secretions of African Green Monkeys Immunized with HPV‐11 Virus‐like Particles Expressed in Yeast. The Journal of Infectious Diseases. 176(5). 1141–1145. 105 indexed citations
5.
Reuman, Peter D., Paul Kubilis, William M. Hurni, Leora Brown, & David R. Nalin. (1997). The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Vaccine. 15(10). 1157–1161. 65 indexed citations
6.
Wiens, Brian L., Norman R. Bohidar, Joseph G. Pigeon, et al.. (1996). Duration of protection from clinical hepatitis A disease after vaccination with VAQTA®. Journal of Medical Virology. 49(3). 235–241. 79 indexed citations
7.
Johnson, Candice E., Mary L. Kumar, BRENDA O. STAEHLE, et al.. (1996). Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. The Pediatric Infectious Disease Journal. 15(8). 687–692. 69 indexed citations
8.
Nalin, David R., et al.. (1995). Monthly Update: Anti-infectives: VAQTA: Merck's hepatitis A vaccine, purified, inactivated. Expert Opinion on Investigational Drugs. 4(12). 1313–1319. 4 indexed citations
9.
Laufer, Dagna, William M. Hurni, Barbara Watson, et al.. (1995). Saliva and Serum as Diagnostic Media for Antibody to Hepatitis A Virus in Adults and in Individuals Who Have Received an Inactivated Hepatitis A Vaccine. Clinical Infectious Diseases. 20(4). 868–871. 16 indexed citations
10.
Kniskern, Peter J., Arpi Hagopian, Loren D. Schultz, et al.. (1994). Characterization and evaluation of a recombinant hepatitis B vaccine expressed in yeast defective for N-linked hyperglycosylation. Vaccine. 12(11). 1021–1025. 24 indexed citations
11.
Hurni, William M., et al.. (1993). Anti‐Hepatitis A in the General Population and in Hepatitis A Vaccinees Using Saliva and Serum as Diagnostic Media. Annals of the New York Academy of Sciences. 694(1). 289–292. 10 indexed citations
12.
Cupps, Thomas R., John A.R. Tibbles, William M. Hurni, et al.. (1993). In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site.. The Journal of Immunology. 151(6). 3353–3360. 19 indexed citations
13.
Miller, William J., et al.. (1993). Sensitive assays for hepatitis a antibodies. Journal of Medical Virology. 41(3). 201–204. 45 indexed citations
14.
Hurni, William M., William J. Miller, Robert Zuk, & Viola T. Kung. (1991). Detection of antibody to the PreS2 sequence of the hepatitis B virus envelope protein using an immuno-ligand assay with a silicon sensor detection system. Journal of Immunological Methods. 145(1-2). 19–26. 6 indexed citations
15.
Hurni, William M., et al.. (1990). Anti‐PreS2 antibody assay for evaluating immune responses among recipients of recombinant hepatitis B PreS2+S vaccine. Journal of Medical Virology. 30(2). 146–150. 5 indexed citations
16.
Kniskern, Peter J., Arpi Hagopian, Diana Montgomery, et al.. (1989). The Application of Molecular Biology to the Development of Novel Vaccines. PubMed. 251. 83–98. 7 indexed citations
17.
Riemen, Mark W., Ronald Wegrzyn, Audrey Baker, et al.. (1987). Isolation of multiple biologically and chemically diverse species of epidermal growth factor. Peptides. 8(5). 877–885. 15 indexed citations
18.
Hurni, William M., et al.. (1986). A robot for performing radioiodinations. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 37(7). 623–627. 3 indexed citations
19.
McAleer, W. J., et al.. (1983). Automated cytopathic effect (CPE) assays. Journal of Biological Standardization. 11(3). 241–IN6. 1 indexed citations
20.
Parker, Bruce C., et al.. (1968). SAMPLER FOR STUDIES OF THIN HORIZONTAL LAYERS. Limnology and Oceanography. 13(1). 172–175. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Clare Walker Breakdown of academic impact, for papers by Santiago Dueñas‐Carrera Breakdown of academic impact, for papers by Julie A. Waterbury Breakdown of academic impact, for papers by Elissa Malkin Breakdown of academic impact, for papers by Li‐Hua Ping Breakdown of academic impact, for papers by Kathie Grovit‐Ferbas Breakdown of academic impact, for papers by James A. Bradac Breakdown of academic impact, for papers by E K Cobb Breakdown of academic impact, for papers by Marintha Heil Breakdown of academic impact, for papers by M J McElrath
Rankless by CCL
2026